http://www.drugs.com/xifaxan.html, Xifaxan, Retrieved June 17, 2012, Drugs.com, 2012.
http://www.fiercebiotech.com/press-releases/fda-approves-xifaxan-550-mg-tablets-reduction-risk-overt-hepatic-encephalopathy-he-re, FDA Approves XIFAXANŽ 550 Mg Tablets For Reduction In Risk Of Overt Hepatic Encephalopathy (HE) Recurrence, Retrieved June 17, 2012, FierceMarkets, 2012.
http://www.hcvadvocate.org/hepatitis/hepC/hepatic_encephalopathy.html, Hepatic Encephalopathy, Liz Highleyman, Retrieved June 17, 2012, Hepatitis C Support Project, 2012.
http://www.liverfoundation.org/abouttheliver/info/hepaticencephalopathy/, Hepatic Encephalopathy, Retrieved June 17, 2012, American Liver Foundation, 2012.
If chronic Hepatitis C escalates to advanced disease that includes hepatic encephalopathy, Lactulose and Xifaxan could be useful medications.
http://www.hepatitis-central.com/mt/archives/2012/06/lactulose_and_x.html
References
http://www.drugs.com/xifaxan.html, Xifaxan, Retrieved June 17, 2012, Drugs.com, 2012.
http://www.fiercebiotech.com/press-releases/fda-approves-xifaxan-550-mg-tablets-reduction-risk-overt-hepatic-encephalopathy-he-re, FDA Approves XIFAXANŽ 550 Mg Tablets For Reduction In Risk Of Overt Hepatic Encephalopathy (HE) Recurrence, Retrieved June 17, 2012, FierceMarkets, 2012.
http://www.hcvadvocate.org/hepatitis/hepC/hepatic_encephalopathy.html, Hepatic Encephalopathy, Liz Highleyman, Retrieved June 17, 2012, Hepatitis C Support Project, 2012.
http://www.liverfoundation.org/abouttheliver/info/hepaticencephalopathy/, Hepatic Encephalopathy, Retrieved June 17, 2012, American Liver Foundation, 2012.